Back

Pre-procedural urine albumin-to-creatinine ratio and one-year major adverse cardiovascular events following percutaneous coronary intervention

30 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: percutaneous coronary intervention and outcomes Percutaneous Coronary Intervention (PCI) and Surgery ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Vincent Zhang

(United States of America)

4 More presentations in this session

Presentation thumbnail
Impact of diabetes mellitus on clinical outcomes after percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era: a systematic review and meta-analysis
Doctor G. Spina (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Diabetes mellitus and 10-year outcomes after percutaneous coronary intervention with drug eluting stents: insights from the DECADE cooperation
Doctor M. Immobile Molaro (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Association of mitochondrial DNA copy number with prior myocardial infarction in patients with coronary artery disease and type 2 diabetes
Doctor Y. Dzhun (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
Socioeconomic disparities in 1-year outcomes after PCI.
Ms S. Janssen (Heerlen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart: percutaneous coronary intervention and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Urinary albumin-to-creatinine ratio and all-cause and cause-specific mortality in chronic kidney disease patients with suspected or known coronary artery disease: the EXCEED-J Study
30 August 2026
thumbnail
Congress Presentation
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
27 August 2023
thumbnail
Congress Presentation
Pre-procedural machine learning model including prior SGLT2 inhibitor therapy improves early risk stratification for contrast-associated kidney injury in acute coronary syndrome
29 August 2026
thumbnail
Congress Presentation
Association of a history of acute kidney injury with major adverse cardiovascular events in chronic kidney disease patients
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources